成纖維細胞生長因子15(FGF15)單克隆抗體
Monoclonal Antibody to Fibroblast Growth Factor 15 (FGF15)
- 編號UMAL154Ra24
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C6
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPL154Ra01-成纖維細胞生長因子15(FGF15)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用IHC
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 373 ¥ 869 ¥ 1242 ¥ 3105 ¥ 12420
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Rat Kidney Tissue; Primary Ab: 20μg/ml Mouse Anti-Rat FGF15 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對FGF15的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別FGF15。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPL154Ra01 | 成纖維細胞生長因子15(FGF15)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPL154Ra01 | 成纖維細胞生長因子15(FGF15)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAL154Ra01 | 成纖維細胞生長因子15(FGF15)多克隆抗體 | WB; IHC |
| UMAL154Ra22 | 成纖維細胞生長因子15(FGF15)單克隆抗體 | IHC |
| UMAL154Ra23 | 成纖維細胞生長因子15(FGF15)單克隆抗體 | IHC |
| UMAL154Ra24 | 成纖維細胞生長因子15(FGF15)單克隆抗體 | IHC |
| UMAL154Ra25 | 成纖維細胞生長因子15(FGF15)單克隆抗體 | IHC |
| UMAL154Ra27 | 成纖維細胞生長因子15(FGF15)單克隆抗體 | IHC |
| UMAL154Ra21 | 成纖維細胞生長因子15(FGF15)單克隆抗體 | IHC |
| UWEL154Ra | 成纖維細胞生長因子15(FGF15)檢測試劑盒(酶聯(lián)免疫吸附試驗法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USEL154Ra | 成纖維細胞生長因子15(FGF15)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UCEL154Ra | 成纖維細胞生長因子15(FGF15)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULML154Ra | 成纖維細胞生長因子15(FGF15)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSL154Ra01 | 成纖維細胞生長因子15(FGF15)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | 自己動手制作ELISA試劑盒的主要材料 |
參考文獻
| 雜志 | 參考文獻 |
| Endocrinology. | Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21 [PubMed: 25774553] |
| Inflammatory Bowel Diseases | Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation [pubmed:27580383] |
| J Lipid Res. | Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis. [pubmed:28130274] |
| BMC Endocrine Disorders | The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance [10.1186/s12902-017-0211-5] |
| Journal?of?Physiology?and?Biochemistry | The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice [Pubmed:29468415] |
| Developmental?Cell | FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis [Pubmed: 30745141] |
| Endocrinology | Interactions between the gravitostat and the fibroblast growth factor system for the regulation of body weight [] |
| Food & Function | Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis [Pubmed: 31626262] |
| Journal of Translational Medicine | Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation [Pubmed: 33036625] |
| Chin Med | Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis [34736501] |
| Int J Biol Sci | Dynamics of the gut-liver axis in rats with varying fibrosis severity [Pubmed:35637968] |
留言咨詢
